Fact Sheet for Healthcare Providers: Roche Molecular Systems, Inc., cobas SARS-CoV-2 & Influenza A/B [open pdf - 172KB]
From the Document: "This Fact Sheet informs you of the significant known and potential risks and benefits of the emergency use of the cobas SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] & Influenza A/B assay. Testing is to be conducted on specimens from individuals suspected of respiratory viral infection consistent with COVID-19 [coronavirus disease 2019] by their healthcare provider. Symptoms of respiratory viral infection due to SARS-CoV-2 and influenza can be similar."
U.S. Food and Drug Administration: https://www.fda.gov/